• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

15.04 -0.51 (-3.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vor Biopharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 ↗
May 16, 2023
 
Via Benzinga
News headline image
8 Analysts Have This to Say About Vor Biopharma ↗
May 15, 2023
 
Via Benzinga
News headline image
Vor Biopharma: Q1 Earnings Insights ↗
May 11, 2023
 
Via Benzinga
News headline image
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
May 11, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
April 18, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Where Vor Biopharma Stands With Analysts ↗
March 24, 2023
 
Via Benzinga
News headline image
Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To Know ↗
March 24, 2023
 
Via Benzinga
News headline image
Dow Rises 50 Points; Oxford Industries Shares Plunge ↗
March 24, 2023
U.S. stocks pared some losses toward the end of trading, with the Dow Jones and S&P 500 turning higher on Friday. The Dow traded up 0.16% to 32,156.53 while the NASDAQ fell 0.16% to 11,768.17. The S&P... 
Via Benzinga
News headline image
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
News headline image
Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
March 23, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
February 21, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant ↗
February 16, 2023
 
Via Benzinga
News headline image
First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level
February 16, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings
January 19, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference
January 12, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Analyzing Vor Biopharma's Short Interest ↗
January 10, 2023
Vor Biopharma's (NASDAQ:VOR) short percent of float has fallen 58.58% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 5.31% of all regular... 
Via Benzinga
News headline image
Dow Edges Higher; Prometheus Biosciences Shares Jump ↗
December 07, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
December 07, 2022
 
Via Benzinga
News headline image
Nasdaq Drops 75 Points; Crude Oil Down 2% ↗
December 07, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday. 
Via Benzinga
News headline image
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
December 07, 2022
 
Via Benzinga
News headline image
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
December 07, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
December 07, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
November 22, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update
November 10, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
November 01, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer
October 12, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment
October 11, 2022
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters
September 28, 2022
Facility to support clinical manufacturing for Vor Bio’s novel cell and genome engineering pipeline while reducing the time and cost required to manufacture its eHSC and CAR-T product candidates 
From Vor Biopharma
Via GlobeNewswire
News headline image
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗
September 20, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap